Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review

Conclusions Lisdexamfetamine dimesylate may have clinical utility for BED in adolescents, but randomized, placebo-controlled studies of its efficacy, tolerability, and safety in this population are needed.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Case Reports Source Type: research